Company / Operating Margin
Tarsus Pharmaceuticals, Inc. Operating Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-15.7%
FY2025
5-year range
-820.5% / -15.7%
FY2021-FY2025
Trend
+76.1%
vs FY2024
Sector context
#64 of 136
Health Care
What the data says
At -15.7%, Tarsus Pharmaceuticals, Inc.'s operating margin ranks #64 of 136 in the Health Care sector. Improved from -820.5% to -15.7% over the past 2 years.
Based on SEC 10-K filings.
-15.7% in FY2025 with a 3-year CAGR of +5.6%.
Improved from -820.5% to -15.7% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +5.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#64 of 136 in Health CareTop 47% of 136This company -15.7% Sector average -778.9%
▼
+98.0% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 76.1% year-over-year.
- Currently 763.2pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -15.7% | +76.1% |
| FY2024 | -65.9% | +92.0% |
| FY2023 | -820.5% | -3748.6% |
| FY2022 | -21.3% | +0.0% |
| FY2021 | -21.3% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026